NEW YORK (Reuters Health) – New evidence indicates that elevated serum levels of ionized calcium may predict the risk of death from prostate cancer. If verified in future…
NEW YORK (Reuters Health) – In a phase I trial involving patients with advanced squamous cell carcinoma of the head and neck (SCCHN), direct intratumoral injection of epithelial…
NEW YORK (Reuters Health) – Treatment with the anti-tumor necrosis factor antibody adalimumab may arrest bone loss in patients with rheumatoid arthritis, according to study results reported in…
NEW YORK (Reuters Health) – The percentages of boys and girls who return to competitive basketball or soccer after anterior cruciate ligament (ACL) repair are similar, according to…
NEW YORK (Reuters Health) – The placement of a permanent pacemaker for dual-chamber pacing had no effect on the frequency of falls among older patients with a history…
NEW YORK (Reuters Health) – For first-line tocolytic therapy before 32 weeks’ gestation, prostaglandin inhibitors appear to be the most effective and tolerable agents for delaying delivery for…
NEW YORK (Reuters Health) – Patients with rectal cancer whose disease is downstaged with neoadjuvant radiation therapy have better survival than their peers who fail to respond to…
NEW YORK (Reuters Health) – A 6-week program of progressive volitional strength training targeting the quadriceps femoris muscle group substantially improves strength and function following total knee arthroplasty…
NEW YORK (Reuters Health) – Yearly gynecological examinations fail to identify early stage ovarian cancer in women with a mutation in the BRCA1 or BRCA2 gene, a Dutch…
NEW YORK (Reuters Health) – Reducing blood pressure with the drug combination perindopril-indapamide reduces renal events in patients with type 2 diabetes, even when the initial blood pressure…
